Page last updated: 2024-10-21

3-hydroxy-4-methoxyphenethylamine and Idiopathic Parkinson Disease

3-hydroxy-4-methoxyphenethylamine has been researched along with Idiopathic Parkinson Disease in 1 studies

3-hydroxy-4-methoxyphenethylamine: cardioactive constituent of a soft coral; cpd is 4-O-methyldopamine; RN given refers to parent cpd
4-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 4 is replaced by a methoxy group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishimitsu, T1
Hirose, S1
Asahara, K1
Imaizumi, M1

Other Studies

1 other study available for 3-hydroxy-4-methoxyphenethylamine and Idiopathic Parkinson Disease

ArticleYear
The formation of 3-hydroxy-4-methoxyphenylalanine and 3-hydroxy-4-methoxyphenethylamine in plasma during L-DOPA therapy in patients with Parkinson's disease.
    Chemical & pharmaceutical bulletin, 1984, Volume: 32, Issue:8

    Topics: Aged; Dopamine; Humans; Levodopa; Methyltyrosines; Parkinson Disease; Tyrosine

1984